
Amanta Healthcare Q2FY27 Revenue Up 17.3% to ₹83.13 Cr
Amanta Healthcare Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. For Q2FY27, the company reported a revenue of ₹83.13 crore, a 17.3% year-on-year increase, driven by price adjustments and sales from a new production line. Profit After Tax (PAT) saw a significant jump of 301.65% YoY to ₹4.86 crore, outpacing revenue growth. EBITDA for the quarter rose 21.9% YoY to ₹17.95 crore, with margins expanding to 21.6%. The company also commissioned SteriPort Line 3, increasing its capacity by 75%, and is on track for SVP expansion by Q1FY28. A 10.8 MW captive solar plant is expected to save approximately ₹9 crore annually. For H1FY27, revenue stood at ₹151.94 crore, up 11.6% YoY, and PAT was ₹8.17 crore, up 12% YoY.
Key Highlights
- Q2FY27 revenue grew 17.3% YoY to ₹83.13 crore.
- PAT surged 301.65% YoY to ₹4.86 crore in Q2FY27.
- EBITDA increased 21.9% YoY to ₹17.95 crore in Q2FY27.
- SteriPort Line 3 commissioned, boosting capacity by 75%.
- SVP expansion targeted for Q1FY28 to drive future growth.
Price Impact
More from AMANTA